{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T10:10:06Z","timestamp":1699351806774},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1007\/s00115-002-1385-1","type":"journal-article","created":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T21:58:25Z","timestamp":1079647105000},"page":"733-739","source":"Crossref","is-referenced-by-count":3,"title":["Die experimentelle Provokation von Panikattacken als humanexperimentelles Angstmodell"],"prefix":"10.1007","volume":"74","author":[{"given":"A.","family":"Str\u00f6hle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1385_C1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0143-4179(91)90126-4","volume":"20","author":"Bidzseranova","year":"1991","unstructured":"Bidzseranova A, Toth G, Telegdy G (1991) The effects of atrial natriuretic peptide on the open-field activity of rats. The role of neurotransmitters. Neuropeptides 20:163\u2013167","journal-title":"Neuropeptides"},{"key":"1385_C2","first-page":"41","volume":"18","author":"Bonn","year":"1973","unstructured":"Bonn JA, Harrison J, Rees L (1973) Lactate infusion in the treatment of 'free-floating' anxiety. Canad Psychiat Ass J 18:41\u201346","journal-title":"Canad Psychiat Ass J"},{"key":"1385_C3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0278-5846(91)90086-G","volume":"15","author":"Bradwejn","year":"1991","unstructured":"Bradwejn J, Koszycki D (1991) Comparison of the panicogenic effects of cholecystokinin 30\u201333 and carbon dioxide in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 15:237\u2013239","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1385_C4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","volume":"48","author":"Bradwejn","year":"1991","unstructured":"Bradwejn J, Koszycki D, Shriqui C (1991) Enhanced sensitivity to cholecystokinin tetrapetide in panic disorder. Arch Gen Psychiatry 48:603\u2013610","journal-title":"Arch Gen Psychiatry"},{"key":"1385_C5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/ajp.151.2.261","volume":"151","author":"Bradwejn","year":"1994","unstructured":"Bradwejn J, Koszycki D (1994) Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. Am J Psychiatry 151:261\u2013263","journal-title":"Am J Psychiatry"},{"key":"1385_C6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0306-4530(87)90061-8","volume":"12","author":"Cameron","year":"1987","unstructured":"Cameron OG, Lee MA, Curtis GC, McCann DS (1987) Endocrine and physiological changes during \"spontaneous\" panic attacks. Psychoneuroendocrinology 12:321\u2013331","journal-title":"Psychoneuroendocrinology"},{"key":"1385_C7","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archpsyc.1986.01800110028005","volume":"43","author":"Charney","year":"1986","unstructured":"Charney DS, Heninger GR (1986) Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 43:1042\u20131054","journal-title":"Arch Gen Psychiatry"},{"key":"1385_C8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archpsyc.1984.01790190025003","volume":"41","author":"Charney","year":"1984","unstructured":"Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:751\u2013763","journal-title":"Arch Gen Psychiatry"},{"key":"1385_C9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","volume":"28","author":"De","year":"1981","unstructured":"De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28:89\u201394","journal-title":"Life Sci"},{"key":"1385_C10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archpsyc.1989.01810060031006","volume":"46","author":"De","year":"1989","unstructured":"De Montigny C (1989) Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers: preliminary findings. Arch Gen Psychiatry 46:511\u2013517","journal-title":"Arch Gen Psychiatry"},{"key":"1385_C11","first-page":"98","volume":"2","author":"Dorow","year":"1982","unstructured":"Dorow R, Horowski R, Paschelke G, Amin M, Braestrup C (1982) Severe anxiety induced by FG 7142 a beta-carboline ligand for benzodiazepine receptors. Lancet 2:98\u201399.","journal-title":"Lancet"},{"key":"1385_C12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archpsyc.1988.01800250035006","volume":"45","author":"Gorman","year":"1988","unstructured":"Gorman JM, Fyer MR, Goetz R et al. (1988) Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 45:31\u201339","journal-title":"Arch Gen Psychiatry"},{"key":"1385_C13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/290514a0","volume":"290","author":"Hunkeler","year":"1981","unstructured":"Hunkeler W, Mohler H, Pieri L, Polc P, Bonetti EP, Cumin R (1981) Selective antagonists of benzodiazepines. Nature 290:514\u2013516","journal-title":"Nature"},{"key":"1385_C14","first-page":"217","volume":"3","author":"Imura","year":"1992","unstructured":"Imura H, Nakao K, Itoh H (1992) The natriuretic peptide system in the brain: Implications in the central control of cardiovascular and neuroendocrine functions. Front Neuroendocrinol 3:217\u2013249","journal-title":"Front Neuroendocrinol"},{"key":"1385_C15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00216062","volume":"96","author":"RS Kahn","year":"1988","unstructured":"Kahn RS, Asnis GM, Wetzler S, van Praag HM (1988) Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology (Berl) 96:360\u2013364","journal-title":"Psychopharmacology (Berl)"},{"key":"1385_C16","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1176\/ajp.152.9.1365","volume":"152","author":"Kellner","year":"1995","unstructured":"Kellner M, Herzog L, Yassouridis A, Holsboer F, Wiedemann K (1995) A possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic. Am J Psychiatry 152:1365\u20131367","journal-title":"Am J Psychiatry"},{"key":"1385_C17","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/0024-3205(92)90543-X","volume":"50","author":"M Kellner","year":"1992","unstructured":"Kellner M, Wiedemann K, Holsboer F (1992) ANF inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci 1992;50:1835\u20131842","journal-title":"Life Sci"},{"key":"1385_C18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/0006-3223(94)00190-E","volume":"37","author":"Kramer","year":"1995","unstructured":"Kramer MS, Cutler NR, Ballenger JC et al. (1995) A placebo-controlled trial of L-365,260, a CCK-B antagonist, in panic disorder. Biol Psychiatry 37:462\u2013466","journal-title":"Biol Psychiatry"},{"key":"1385_C19","doi-asserted-by":"crossref","unstructured":"Lesch KP, Wiesmann M, Hoh A, Muller T, Disselkamp-Tietze J, Osterheider M, Schulte HM (1992) 5-HT1A receptor-effector system responsivity in panic disorder. Psychopharmacology (Berl) 106:111\u2013117","DOI":"10.1007\/BF02253597"},{"key":"1385_C20","first-page":"122","volume":"17","author":"Liebowitz","year":"1981","unstructured":"Liebowitz MR, Fyer AJ, McGranth P (1981) Clonidine treatment of panic disorder. Psychopharmacol Bull 17:122\u2013123","journal-title":"Psychopharmacol Bull"},{"key":"1385_C21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archpsyc.1990.01810220033004","volume":"47","author":"Nutt","year":"1990","unstructured":"Nutt DJ, Glue P, Lawson C, Wilson S (1990) Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 47:917\u2013925","journal-title":"Arch Gen Psychiatry"},{"key":"1385_C22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0006-3223(97)86929-6","volume":"42","author":"Pande","year":"1997","unstructured":"Pande CA (1997) Lack of efficacy of a cholecystokinin-B antagonist in anxiety disorders. Biol Psychiatry 42:11\u201319","journal-title":"Biol Psychiatry"},{"key":"1385_C23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1176\/ajp.153.8.1060","volume":"153","author":"Perna","year":"1996","unstructured":"Perna G, Bertani A, Caldirola D, Bellodi L (1996) Family history of panic disorder and hypersensitivity to CO2 in patients with panic disorder. Am J Psychiatry 153:1060\u20131064","journal-title":"Am J Psychiatry"},{"key":"1385_C24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM196712212772502","volume":"177","author":"Pitts","year":"1967","unstructured":"Pitts FM, McClure JN (1967) Lactate metabolism in anxiety neurosis. New England J Med 177:1329\u20131336","journal-title":"New England J Med"},{"key":"1385_C25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0143-4179(92)90157-R","volume":"22","author":"Poggioli","year":"1992","unstructured":"Poggioli R, Vergoni AV, Rasori E, Marrama D, Bertolini A (1992) Behavioral effects of atriopeptin in rats. Neuropeptides 22:149\u2013154","journal-title":"Neuropeptides"},{"key":"1385_C26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0006-3223(94)00306-N","volume":"138","author":"Randall","year":"1995","unstructured":"Randall PK, Bremner JD, Krystal JH, Nagy LM, Heninger GR, Nicolaou AL, Charney DS (1995) Effects of the benzodiazepine antagonist flumazenil in PTSD. Biol Psychiatry 138:319\u2013324","journal-title":"Biol Psychiatry"},{"key":"1385_C27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-3956(98)00014-4","volume":"32","author":"V Reed","year":"1998","unstructured":"Reed V, Wittchen HU (1998) DSM-IV panic attacks and panic disorder in a community sample of adolescents and young adults: how specific are panic attacks? J Psychiatric Res 32:335\u2013345","journal-title":"J Psychiatric Res"},{"key":"1385_C28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/archpsyc.1990.01810180034006","volume":"47","author":"PP Roy-Byrne","year":"1990","unstructured":"Roy-Byrne PP, Cowley DS, Greenblatt DJ, Shader RI, Hommer D (1990) Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry. 47:534\u2013538","journal-title":"Arch Gen Psychiatry."},{"key":"1385_C29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2007-1017413","volume":"17","author":"Sch\u00f6pf","year":"1984","unstructured":"Sch\u00f6pf J, Laurian S, Gaillard JM (1984) Intrinsic activity of the benzodiazepine antagonist Ro 15\u20131788 in man. An electrophysiological investigation. Pharmacopsychiatry 17:79\u201383","journal-title":"Pharmacopsychiatry"},{"key":"1385_C30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-1781(91)90013-F","volume":"38","author":"Seibyl","year":"1991","unstructured":"Seibyl JP, Krystal JH, Price LH, Woods SW, D'Amico C, Heninger GR, Charney DS (1991) Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects. Psychiatry Res 38:227\u2013236","journal-title":"Psychiatry Res"},{"key":"1385_C31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1176\/ajp.148.1.142-b","volume":"148","author":"Shear","year":"1991","unstructured":"Shear MK, Fyer AJ, Ball G et al. (1991) Vulnerability to sodium lactate in panic disorder patients given cognitive behavioral therapy. Am J Psychiatry 148:795\u2013797","journal-title":"Am J Psychiatry"},{"key":"1385_C32","first-page":"332","volume":"22","author":"Shlik","year":"1997","unstructured":"Shlik J, Aluoja A, Vasar V, Vasar E, Podar T, Bradwejn J (1997) Effects of citalopram treatment on behavioral cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Psychiatry Neurosci 22:332\u2013340","journal-title":"J Psychiatry Neurosci"},{"key":"1385_C33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF02245206","volume":"113","author":"Steiger","year":"1994","unstructured":"Steiger A, Guldner J, Lauer CJ, Meschenmoser C, Pollm\u00e4cher T, Holsboer F (1994) Flumazenil exerts intrinsic activity on sleep EEG and nocturnal hormone secretion. Psychopharmacology 113:334\u2013338","journal-title":"Psychopharmacology"},{"key":"1385_C34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000127274","volume":"65","author":"Str\u00f6hle","year":"1997","unstructured":"Str\u00f6hle A, Jahn H, Montkowski A et al. (1997) Central and peripheral administration of atriopeptin is anxiolytic in rats. Neuroendocrinology 65:210\u2013215","journal-title":"Neuroendocrinology"},{"key":"1385_C35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1176\/ajp.155.5.610","volume":"155","author":"Str\u00f6hle","year":"1998","unstructured":"Str\u00f6hle A, Kellner M, Yassouridis A, Holsboer F, Wiedemann K (1998) Effect of flumazenil in lactate-sensitive patients with panic disorder. Am J Psychiatry 155:610\u2013612","journal-title":"Am J Psychiatry"},{"key":"1385_C36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0006-3223(97)00200-X","volume":"43","author":"Str\u00f6hle","year":"1998","unstructured":"Str\u00f6hle A, Kellner M, Holsboer F, Wiedemann K (1998) Atrial natriuretic hormone decreases endocrine response to a combined dexamethasone corticotropin-releasing hormone test. Biol Psychiatry 43:371\u2013375","journal-title":"Biol Psychiatry"},{"key":"1385_C37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0006-3223(98)00295-9","volume":"45","author":"Str\u00f6hle","year":"1999","unstructured":"Str\u00f6hle A, Kellner M, Holsboer F, Wiedemann K (1999) Behavioral, neuroendocrine and cardiovascular response to flumazenil. No evidence for an altered benzodiazepine receptor sensitivity in panic disorder. Biol Psychiatry 45:321\u2013326","journal-title":"Biol Psychiatry"},{"key":"1385_C38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0893-133X(99)00115-3","volume":"22","author":"Str\u00f6hle","year":"2000","unstructured":"Str\u00f6hle A, Holsboer F, Rupprecht R (2000) Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Neuropsychopharmacology 22:251\u2013256","journal-title":"Neuropsychopharmacology"},{"key":"1385_C39","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1176\/appi.ajp.158.9.1514","volume":"158","author":"Str\u00f6hle","year":"2001","unstructured":"Str\u00f6hle A, Kellner M, Holsboer F, Wiedemann K (2001) Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder. Am J Psychiatry 158:1514\u20131516","journal-title":"Am J Psychiatry"},{"key":"1385_C40","unstructured":"Str\u00f6hle A, Romeo E, di Michele F, Pasini A et al. (\u275ain press) Induced panic attacks shift GABAA receptor modulatory neuroactive steroid composition in patients with panic disorder. Preliminary results. Arch Gen Psychiatry"},{"key":"1385_C41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/332078a0","volume":"332","author":"T Sudoh","year":"1988","unstructured":"Sudoh T, Kangawa K, Minamino N, Matsuo H (1988) A new natriuretic peptide in porcine brain. Nature 1988;332:78\u201381","journal-title":"Nature"},{"key":"1385_C42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.213833","volume":"202","author":"Svenson","year":"1978","unstructured":"Svenson TH, Usdin T (1978) Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha-receptor mediation. Science 202:1089\u20131091","journal-title":"Science"},{"key":"1385_C43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0165-1781(89)90210-2","volume":"28","author":"Targum","year":"1989","unstructured":"Targum SD, Marshall LE (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res 28:295\u2013306","journal-title":"Psychiatry Res"},{"key":"1385_C44","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/archpsyc.58.4.371","volume":"58","author":"Wiedemann","year":"2001","unstructured":"Wiedemann K, Jahn H, Yassouridis A, Kellner M (2001) Anxiolytic activity of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks. Arch Gen Psychiatry 58:371\u2013377","journal-title":"Arch Gen Psychiatry"},{"key":"1385_C45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archpsyc.1987.01800160077010","volume":"44","author":"Woods","year":"1987","unstructured":"Woods SW, Charney DS, McPherson CA, Gradman AH, Heninger GR (1987) Situational panic attacks. Behavioral physiologic and biochemical characterization. Arch Gen Psychiatry 44:365\u2013375","journal-title":"Arch Gen Psychiatry"},{"key":"1385_C46","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0893-133X(01)00266-4","volume":"25","author":"Zwansger","year":"2001","unstructured":"Zwansger P, Baghai TC, Schuele C et al. (2001) Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Neuropsychopharmacology 25:699\u2013703","journal-title":"Neuropsychopharmacology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-002-1385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-002-1385-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-002-1385-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-002-1385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T09:29:01Z","timestamp":1699349341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-002-1385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1007\/s00115-002-1385-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}